Hypoxia within head and neck squamous cell cancer metastatic lymph nodes is associated with poorer outcomes following chemoradiotherapy when measured directly using polarographic probes.
The utility of non-invasive pretreatment T2* measurement in prediction of chemoradiotherapeutic response was investigated. Our data suggest, however, that nodes demonstrating sustained post-therapy complete local response based on two-year follow-up are significantly more hypoxic compared with relapsing-nodes and paradoxically demonstrate a significant increase in hypoxia on breathing 100%-oxygen.
Following further work to ascertain the mechanisms of these observed changes, the differential response to oxygen and lower baseline oxygenation in responding-nodes could be exploited in risk stratification.
This abstract and the presentation materials are available to members only; a login is required.